Caris Life Sciences, Inc. 4

President David Baxley Spetzler had 13,856 Caris Life Sciences, Inc. common shares withheld on May 15, 2026 to cover taxes on RSU vesting, leaving him with 530,083 shares owned.

On May 15, 2026, President David Baxley Spetzler of Caris Life Sciences, Inc. had 13,856 shares of common stock withheld by the company at an implied price of $15.25 per share, totaling approximately $211,304, to cover taxes due upon the vesting and settlement of previously granted RSUs. This Form 4 reflects a routine tax-withholding transaction coded as an "F" (payment of exercise price or tax liability by delivering or withholding securities) rather than an open-market sale, leaving Spetzler with 530,083 shares of common stock directly owned after the transaction. The event represents standard equity compensation administration and not a discretionary buy or sell decision in the open market.

Filing Facts

CIK

2019410

Ticker

CAI

Form

4

Source Type

fda

Accession

0002071953-26-000004

Alert Tier

5